These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
357 related items for PubMed ID: 27956407
1. Coronary Plaque Morphology and the Anti-Inflammatory Impact of Atorvastatin: A Multicenter 18F-Fluorodeoxyglucose Positron Emission Tomographic/Computed Tomographic Study. Singh P, Emami H, Subramanian S, Maurovich-Horvat P, Marincheva-Savcheva G, Medina HM, Abdelbaky A, Alon A, Shankar SS, Rudd JH, Fayad ZA, Hoffmann U, Tawakol A. Circ Cardiovasc Imaging; 2016 Dec; 9(12):e004195. PubMed ID: 27956407 [Abstract] [Full Text] [Related]
2. Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility study. Tawakol A, Fayad ZA, Mogg R, Alon A, Klimas MT, Dansky H, Subramanian SS, Abdelbaky A, Rudd JH, Farkouh ME, Nunes IO, Beals CR, Shankar SS. J Am Coll Cardiol; 2013 Sep 03; 62(10):909-17. PubMed ID: 23727083 [Abstract] [Full Text] [Related]
3. Effects of Statins on Coronary Atherosclerotic Plaques: The PARADIGM Study. Lee SE, Chang HJ, Sung JM, Park HB, Heo R, Rizvi A, Lin FY, Kumar A, Hadamitzky M, Kim YJ, Conte E, Andreini D, Pontone G, Budoff MJ, Gottlieb I, Lee BK, Chun EJ, Cademartiri F, Maffei E, Marques H, Leipsic JA, Shin S, Choi JH, Chinnaiyan K, Raff G, Virmani R, Samady H, Stone PH, Berman DS, Narula J, Shaw LJ, Bax JJ, Min JK. JACC Cardiovasc Imaging; 2018 Oct 03; 11(10):1475-1484. PubMed ID: 29909109 [Abstract] [Full Text] [Related]
5. 18F-sodium fluoride positron emission tomography for molecular imaging of coronary atherosclerosis based on computed tomography analysis. Kitagawa T, Yamamoto H, Toshimitsu S, Sasaki K, Senoo A, Kubo Y, Tatsugami F, Awai K, Hirokawa Y, Kihara Y. Atherosclerosis; 2017 Aug 03; 263():385-392. PubMed ID: 28528743 [Abstract] [Full Text] [Related]
6. Relationship Between Serum Inflammatory Marker Levels and the Dynamic Changes in Coronary Plaque Characteristics After Statin Therapy. Kwon O, Kang SJ, Kang SH, Lee PH, Yun SC, Ahn JM, Park DW, Lee SW, Kim YH, Lee CW, Han KH, Park SW, Park SJ. Circ Cardiovasc Imaging; 2017 Jul 03; 10(7):. PubMed ID: 28679524 [Abstract] [Full Text] [Related]
7. Coronary 18F-Fluoride Uptake and Progression of Coronary Artery Calcification. Doris MK, Meah MN, Moss AJ, Andrews JPM, Bing R, Gillen R, Weir N, Syed M, Daghem M, Shah A, Williams MC, van Beek EJR, Forsyth L, Dey D, Slomka PJ, Dweck MR, Newby DE, Adamson PD. Circ Cardiovasc Imaging; 2020 Dec 03; 13(12):e011438. PubMed ID: 33297761 [Abstract] [Full Text] [Related]
8. Anti-inflammatory effect of statin is continuously working throughout use: a prospective three time point 18F-FDG PET/CT imaging study. Kang MK, Kim CJ, Choo EH, Han EJ, Hwang BH, Kim JJ, Kim SH, O JH, Chang K. Int J Cardiovasc Imaging; 2019 Sep 03; 35(9):1745-1753. PubMed ID: 31312997 [Abstract] [Full Text] [Related]
9. Pioglitazone decreases coronary artery inflammation in impaired glucose tolerance and diabetes mellitus: evaluation by FDG-PET/CT imaging. Nitta Y, Tahara N, Tahara A, Honda A, Kodama N, Mizoguchi M, Kaida H, Ishibashi M, Hayabuchi N, Ikeda H, Yamagishi S, Imaizumi T. JACC Cardiovasc Imaging; 2013 Nov 03; 6(11):1172-82. PubMed ID: 24229770 [Abstract] [Full Text] [Related]
11. Assessment of artery calcification in atherosclerosis with dynamic 18F-FDG-PET/CT imaging in elderly subjects. Al-Enezi MS, Abdo RA, Mokeddem MY, Slimani FAA, Khalil A, Fulop T, Turcotte E, Bentourkia M. Int J Cardiovasc Imaging; 2019 May 03; 35(5):947-954. PubMed ID: 30712152 [Abstract] [Full Text] [Related]
12. Relationship of serum inflammatory biomarkers with plaque inflammation assessed by FDG PET/CT: the dal-PLAQUE study. Duivenvoorden R, Mani V, Woodward M, Kallend D, Suchankova G, Fuster V, Rudd JHF, Tawakol A, Farkouh ME, Fayad ZA. JACC Cardiovasc Imaging; 2013 Oct 03; 6(10):1087-1094. PubMed ID: 24135322 [Abstract] [Full Text] [Related]
13. The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: a multicenter FDG-PET trial. Emami H, Vucic E, Subramanian S, Abdelbaky A, Fayad ZA, Du S, Roth E, Ballantyne CM, Mohler ER, Farkouh ME, Kim J, Farmer M, Li L, Ehlgen A, Langenickel TH, Velasquez L, Hayes W, Tawakol A. Atherosclerosis; 2015 Jun 03; 240(2):490-6. PubMed ID: 25913664 [Abstract] [Full Text] [Related]
14. Effect of Liraglutide on Arterial Inflammation Assessed as [18F]FDG Uptake in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial. Ripa RS, Zobel EH, von Scholten BJ, Jensen JK, Binderup T, Diaz LJ, Curovic VR, Hansen TW, Rossing P, Kjaer A. Circ Cardiovasc Imaging; 2021 Jul 03; 14(7):e012174. PubMed ID: 34187185 [Abstract] [Full Text] [Related]